治疗性ERCP在85岁以上高龄患者中的应用价值评价

目的 评价治疗性ERCP在85岁以上高龄老年人的安全性和有效性.方法 回顾性分析2004年至2009年间85岁以上ERCP患者（A组,52例）的临床资料,并与同期70～84岁ERCP患者（B组,329例）做比较.结果 A组患者伴发症（52/52）明显高于B组（255/329）,P〈0.05;对于胆总管结石者,需要多次取清结石者A组（19/52）明显多于B组（65/329）,P〈0.05;并发症发生率分别为（4/52）和（16/329）,P〉0.05;术后死亡率分别为（1/52）和（2/329）,P〉0.05.结论 治疗性ERCP对于85岁以上高龄老年人是安全有效的,但需严格掌握手术适应证.

Therapeutic endoscopic retrograde cholangiopancreatography in patients aging over 85

Objective To evaluate the safely and efficacy of therapeutic endoscopic retrograde cholangiopancreatography (ERCP) and its related procedures in patients older than 85 years.Methods Data of patients older than 85 who underwent ERCP between 2004 and 2009 (group A, n =52) were reviewed and compared with those of patients aging 70-84 years (group B, n = 329).Results The rate of patients with underlying disorders of other systems in group A was significantly greater than that of group B (100.0% vs.77.5% , P < 0.05) , as well as the rate of multiple procedures to achieve stone clearance (42.3% vs.28.8% , P <0.05).There were no significant differences between 2 groups regarding the rates of complication (7.7% vs.4.9% ) and post-procedure mortality (1.9% vs.0.6% ).Conclusion Therapeutic ERCP and related procedures are safe and effective in patients aging over 85, and advanced age should not be regarded as the contraindication of the procedure.